| (210) | Number of the EPO application | 16918763 |
| (220) | Filing date of the EPO application | 2016.12.12 |
| (80) | EPO patent specification publication (B) | EPB nr. 41/2021, 2021.10.13 |
| (110) | EPO patent number | 3524601 |
| (11) | Number of the document | MD 3524601 T2 |
| (21) | Number of the application | e 2019 0893 |
| (71) | Name(s) of applicant(s), code of the country | R-Pharm Joint Stock Company (R-Pharm, JSC), RU;
Repik, Alexey Evgenievich, RU; |
| (72) | Name(s) of inventor(s), code of the country | REPIK Alexey Evgenievich, RU;
IVACHTCHENKO Alexandre Vasilievich, US;
IGNATIEV Vasily Gennadievich, RU;
CHAFEEV Mikhail Airatovich, RU; |
| (73) | Name(s) of owner(s), code of the country | R-Pharm Joint Stock Company (R-Pharm, JSC), RU;
Repik, Alexey Evgenievich, RU; |
| (54) | Title of the invention | N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodophenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2h-pyrido[4,3-d]pyrimidin-1-yl]-phenyl}-cyclopropanecarboxamide dimethyl sulphoxide solvate as an mek1/2 inhibitor |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07D 471/04 (2006.01.01); A61P 35/00 (2006.01.01); A61K 31/519 (2006.01.01) |
| (19) | Country | RU |
| (41) | Date of publication of the application | 2019.09.30 |
| (49) | Date of publication of the translation of the validated European patent specification | 2022.02.28 |
| (30) | Priority | 2016139641, 2016.10.10, RU |
| (74) | Patent attorney | (Procedură) GLAZUNOV Nicolae, Str. Trandafirilor nr. 31, bloc 1, ap. 111, MD-2038, Chişinău, Republica Moldova |
| (86) | International application | PCT/RU2016/000862, 2016.12.12 |
| (87) | International publication | WO 2018/070900, 2018.04.19 |